336
Participants
Start Date
April 30, 2021
Primary Completion Date
August 12, 2022
Study Completion Date
May 23, 2023
Core Treatment Active Experimental: SHR0302 Dose#1
Drug: SHR0302 Oral tablets taken once daily (QD) for 16 weeks
Core Treatment Active Experimental: SHR0302 Dose#2
Drug: SHR0302 Oral tablets taken once daily (QD) for 16 weeks
Core Treatment Placebo Comparator: Placebo
Drug: Placebo Oral tablets taken once daily (QD) for 16 weeks
Extension Treatment Active Experimental: SHR0302 Dose#1
Drug: SHR0302 Oral tablets taken once daily (QD) for 36 weeks
Extension Treatment Active Experimental: SHR0302 Dose#2
Drug: SHR0302 Oral tablets taken once daily (QD) for 36 weeks
Peking University People's Hospital, Beijing
Beijing Children's Hospital, Capital Medical University, Beijing
Peking University third hospital, Beijing
Peking union medical college hospital, Beijing
The first hospital of China medical university, Shenyang
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Zhejiang province People's Hospital, Hangzhou
Xiangya Hospital of Central South University, Changsha
The Third Xiangya Hospital of Central South University, Changsha
Dermatology Research Institute Inc., Calgary
Dr Chih-ho Hong Medical Inc., Surrey
Enverus Medical Research, Surrey
Wiseman Dermatology Research, Winnipeg
CCA Medical Research, Ajax
SKiN Health, Cobourg
DermEffects, London
North York Research Inc., North York
The Centre for Dermatology, Richmond Hill
York Dermatology, Richmond Hill
Toronto Research Centre, Toronto
Research Toronto, Toronto
AvantDerm, Toronto
XLR8 Clinical Research, Windsor
Clinique D, Laval
First Affiliated Hospital of Anhui Medical University, Hefei
The second Affiliated Hospital of Anhui Medical University, Hefei
First Affiliated Hospital of Fujian Medical University, Fuzhou
Zhongshan Hospital, Fudan University(Xiamen Branch), Xiamen
Dermatology Hospital of Southern Medical University, Guangzhou
Guangdong Province Traditional Chinese Medical Hospital, Guangzhou
The First affiliated Hospital, Sun Yat-sen University, Guangzhou
Wuhan No.1 Hospital, Wuhan
The Second Xiangya Hospital of Central South University, Changsha
Hospital for Skin Diseases, Chinese Academy of medical sciences, Nanjing
Jiangsu province people's hospital, Nanjing
Wuxi No.2 People's Hospital, Wuxi
Affiliated Hospital of Jiangsu University, Zhenjiang
Jiangxi Provincial Hospital of Dermatology, Nanchang
The First Affiliated Hospital of Nanchang University, Nanchang
The second Affiliated Hospital of Nanchang University, Nanchang
The first hospital of jilin university, Changchun
West China Hospital of Sichuan University, Chengdu
The Children's Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou
The first people's hospital of hangzhou, Hangzhou
The fourth hospital affiliated to zhejiang university school of medicine, Yiwu
Children's Hospital Capital Institute of Pediatrics, Beijing
Chongqing Traditional Chinese medicine Hospital, Chongqing
First affiliated hospital of chongqing medical university, Chongqing
The Southwest Hospital of AMU, Chongqing
Dermatology hospital of Shanghai, Shanghai
Huashan Hospital Affiliated to Fudan University, Shanghai
Reistone Biopharma Company Limited
INDUSTRY